These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 7584503)

  • 1. Considerations in the design and production of small anti-receptor antibody forms: optimizing gains while reducing size.
    Peterson NC; Greene MI
    Ther Immunol; 1994 Oct; 1(5):289-95. PubMed ID: 7584503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
    Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.
    Burioni R; Bugli F; Mancini N; Rosa D; Di Campli C; Moroncini G; Manzin A; Abrignani S; Varaldo PE; Clementi M; Fadda G
    Virology; 2001 Sep; 288(1):29-35. PubMed ID: 11543655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High level production of functional antibody Fab fragments in an oxidizing bacterial cytoplasm.
    Venturi M; Seifert C; Hunte C
    J Mol Biol; 2002 Jan; 315(1):1-8. PubMed ID: 11771962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recombinant design and expression of human three-domain antibody against BoNTa].
    Wang H; Yin J; Shi J; Meng LL; Li PZ
    Wei Sheng Wu Xue Bao; 2005 Apr; 45(2):223-5. PubMed ID: 15989265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
    Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
    J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition.
    Calarese DA; Scanlan CN; Zwick MB; Deechongkit S; Mimura Y; Kunert R; Zhu P; Wormald MR; Stanfield RL; Roux KH; Kelly JW; Rudd PM; Dwek RA; Katinger H; Burton DR; Wilson IA
    Science; 2003 Jun; 300(5628):2065-71. PubMed ID: 12829775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant anti-stefin A Fab fragment: sequence analysis of the variable region and expression in Escherichia coli.
    Kopitar-Jerala N; Gubensek F; Turk V
    Biol Chem; 2000 Dec; 381(12):1245-9. PubMed ID: 11209759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humanization of an anti-human IL-6 mouse monoclonal antibody glycosylated in its heavy chain variable region.
    Sato K; Ohtomo T; Hirata Y; Saito H; Matsuura T; Akimoto T; Akamatsu K; Koishihara Y; Ohsugi Y; Tsuchiya M
    Hum Antibodies Hybridomas; 1996; 7(4):175-83. PubMed ID: 9140729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic analysis of recombinant antibody-antigen interactions: relation between structural domains and antigen binding.
    Borrebaeck CA; Malmborg AC; Furebring C; Michaelsson A; Ward S; Danielsson L; Ohlin M
    Biotechnology (N Y); 1992 Jun; 10(6):697-8. PubMed ID: 1368889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of the anti-His tag antibody 3D5 single-chain fragment complexed to its antigen.
    Kaufmann M; Lindner P; Honegger A; Blank K; Tschopp M; Capitani G; Plückthun A; Grütter MG
    J Mol Biol; 2002 Apr; 318(1):135-47. PubMed ID: 12054774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Production of phage-displayed anti-idiotypic antibody single chain variable fragments to MG7 monoclonal antibody directed against gastric carcinoma].
    He F; Nie Y; Han Z
    Zhonghua Yi Xue Za Zhi; 2001 Jan; 81(1):33-6. PubMed ID: 11798849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and characterization of two anti-sweetener single chain antibodies using radioligand binding, fluorescence and circular dichroism spectroscopy.
    Pledger DW; Brodnicki TC; Graham BL; Tetin S; Kranz DM; Linthicum DS
    J Mol Recognit; 1999; 12(4):258-66. PubMed ID: 10440997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and purification of monospecific and bispecific recombinant antibody fragments derived from antibodies that block the CD80/CD86-CD28 costimulatory pathway.
    Dincq S; Bosman F; Buyse MA; Degrieck R; Celis L; de Boer M; Van Doorsselaere V; Sablon E
    Protein Expr Purif; 2001 Jun; 22(1):11-24. PubMed ID: 11388794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and binding of intracellular antibody fragments to the hepatitis C virus core protein.
    Heintges T; zu Putlitz J; Wands JR
    Biochem Biophys Res Commun; 1999 Sep; 263(2):410-8. PubMed ID: 10491307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designer genes: recombinant antibody fragments for biological imaging.
    Wu AM; Yazaki PJ
    Q J Nucl Med; 2000 Sep; 44(3):268-83. PubMed ID: 11105590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibody affinity].
    Torosian ATs
    Usp Sovrem Biol; 1980; 89(3):419-32. PubMed ID: 6251656
    [No Abstract]   [Full Text] [Related]  

  • 18. Applications of single-chain variable fragment antibodies in therapeutics and diagnostics.
    Weisser NE; Hall JC
    Biotechnol Adv; 2009; 27(4):502-20. PubMed ID: 19374944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
    Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
    J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-ray structures of fragments from binding and nonbinding versions of a humanized anti-CD18 antibody: structural indications of the key role of VH residues 59 to 65.
    Eigenbrot C; Gonzalez T; Mayeda J; Carter P; Werther W; Hotaling T; Fox J; Kessler J
    Proteins; 1994 Jan; 18(1):49-62. PubMed ID: 7908437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.